Public Health Europe - European Commission - EU
Helga Festøy, Head of Unit, Safe Use, at the Norwegian Medicines Agency talks about a new development in the EURIPID collaboration, which helps make information about pharmaceuticals available to national authorities and makes it easier for them to control costs.
These Guidelines by the Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) concern guidance on how to perform benefit-risk assessment of phthalates used in certain medical devices. Deadline for comments is 29 April 2019.
Simona Martin, Scientific Officer at the European Commission Joint Research Centre, talks about the new European Platform on Rare Disease Registration launched at the occasion of Rare Disease Day on February 28.
Carina Dantas, Innovation Director at Cáritas Coimbra, explains why her organisation is an active member of the EU Health Policy Platform and hosted one of the platform's previous cycle of thematic networks, Smart Healthy Age-Friendly Environments (SHAFE).
The conference will bring together patients, advocacy groups, leading professionals, transplant agencies, national authorities as well as EU institutions for a unique exchange of views on their common aim: increasing organ donation and transplantation in the EU. EUDONORGAN is a project funded by the EU.